Amber Joy Gustafson, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2845 Us 2 & 41, Suite 201, Bark River, MI 49807 Phone: 906-466-2000 Fax: 906-466-2067 |
News Archive
The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment.
Impax Laboratories (Netherlands) B.V., a wholly owned subsidiary of Impax Laboratories, Inc. today announced that it has submitted a Marketing Authorization Application for IPX066 to the European Medicines Agency. IPX066 is an investigational extended-release capsule formulation of carbidopa-levodopa for the treatment of idiopathic Parkinson's disease.
Children play harder and longer when their child-care centers provide portable play equipment such as balls and jump ropes, more opportunities for active play and physical activity training and education for staff and students, according to researchers at the University of North Carolina at Chapel Hill School of Public Health.
OXIS INTERNATIONAL, INC. is proud to announce that it has initiated active planning for the First World Congress on Ergothioneine, to be held in Los Angeles, California in July 2011 (the specific date will be announced at a later date).
› Verified 9 days ago